FATE - CIK 0001434316
The table below shows FATE THERAPEUTICS INC's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $39.57M | $40.62M | $41.25M | $44.92M | $37.91M | $36.92M |
| Short-term investments | $135.25M | $174.80M | $181.58M | $195.50M | $259.01M | $267.96M |
| Receivables | $704.00K | $682.00K | $1.40M | $2.41M | $4.13M | $1.05M |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $179.53M |
| $221.25M |
| $230.40M |
| $248.22M |
| $310.29M |
| $319.39M |
| Property, plant & equipment | $54.26M | $59.48M | $61.10M | $62.76M | $82.39M | $87.53M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $284.92M | $343.67M | $371.63M | $398.67M | $494.97M | $528.82M |
| Accounts payable | $3.28M | $3.50M | $4.04M | $4.19M | $6.35M | $5.50M |
| Total current liabilities | $30.69M | $28.11M | $28.67M | $28.16M | $37.42M | $34.79M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | - | - | - | - | - | - |
| Retained earnings | -$1.57B | -$1.50B | -$1.47B | -$1.44B | -$1.35B | -$1.30B |
| Total equity | $179.71M | $234.07M | $261.36M | $288.41M | $362.33M | $396.98M |